Comparison of the real-world efficacy and safety of romiplostim and recombinant human thrombopoietin (rhTPO) in chemotherapy-induced thrombocytopenia

Abstract Objective This study retrospectively compared the efficacy and safety of romiplostim and recombinant human thrombopoietin (rhTPO) in managing chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumours, aiming to provide valuable evidence for clinical practice in CIT manageme...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yu Cheng, Juan Wei, Fang Zhu, Liang Xuan, Yuan Li, Lei Meng, Chuandong Zhu, Huihui Zhao
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2026-02-01
Edice:	BMC Cancer
Témata:	Romiplostim Recombinant human thrombopoietin Chemotherapy-induced thrombocytopenia Solid tumours Platelet recovery
On-line přístup:	https://doi.org/10.1186/s12885-026-15678-z
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!